Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 141 - 150 of 688 shown below

  • Odell, E

    I S Scott, E Odell, P Chatrath, L S Morris, R J Davies, S L Vowler, R A Laskey and N Coleman

    A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia

    doi:10.1038/sj.bjc.6603066

  • Oden, A

    L E Tisell, A Oden, A Muth, G Altiparmak, J Mõlne, H Ahlman and O Nilsson

    The Ki67 index a prognostic marker in medullary thyroid carcinoma

    doi:10.1038/sj.bjc.6601453

  • Oden-Gangloff, A

    A Oden-Gangloff, F Di Fiore, F Bibeau, A Lamy, G Bougeard, F Charbonnier, F Blanchard, D Tougeron, M Ychou, F Boissière, F Le Pessot, J-C Sabourin, J-J Tuech, P Michel and T Frebourg

    TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy

    doi:10.1038/sj.bjc.6605008

  • Odenbro, Å

    Å Odenbro, R Bellocco, P Boffetta, B Lindelöf and J Adami

    Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden

    advance online publication, 2005-03-15 00:00:00.000;

    doi:10.1038/sj.bjc.6602475

  • Odermatt, B

    C Marty, B Odermatt, H Schott, D Neri, K Ballmer-Hofer, R Klemenz and R A Schwendener

    Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

    doi:10.1038/sj.bjc.6600423

  • S M Zeisberger, B Odermatt, C Marty, A H M Zehnder-Fjällman, K Ballmer-Hofer and R A Schwendener

    Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

    advance online publication, 2006-07-11 00:00:00.000;

    doi:10.1038/sj.bjc.6603240

  • Odicino, F E

    E Bignotti, A Ravaggi, R A Tassi, S Calza, E Rossi, M Falchetti, C Romani, E Bandiera, F E Odicino, S Pecorelli and A D Santin

    Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas

    advance online publication, 2008-08-05 00:00:00.000;

    doi:10.1038/sj.bjc.6604546

  • Odumosu, O

    S Khan, J R Aspe, M G Asumen, F Almaguel, O Odumosu, S Acevedo-Martinez, M De Leon, W H R Langridge and N R Wall

    Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604978

  • Odutoye, T

    L Pitkin, S Luangdilok, C Corbishley, P O G Wilson, P Dalton, D Bray, S Mady, P Williamson, T Odutoye, P Rhys Evans, K N Syrigos, C M Nutting, Y Barbachano, S Eccles and K J Harrington

    Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival

    advance online publication, 2007-08-07 00:00:00.000;

    doi:10.1038/sj.bjc.6603907

  • Odze, R D

    M H Kulke, R D Odze, K S Thakore, G Thomas, H Wang, M Loda and C Eng

    Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma

    doi:10.1054/bjoc.2000.1660

  • Oechsle, K

    C Bokemeyer, C Kollmannsberger, K Oechsle, B M Dohmen, A Pfannenberg, C D Claussen, R Bares and L Kanz

    Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET

    doi:10.1038/sj.bjc.6600122

  • C Bokemeyer, K Oechsle, J T Hartmann, P Schöffski, N Schleucher, B Metzner, J Schleicher and L Kanz

    Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer

    doi:10.1038/sj.bjc.6600629

  • J T Hartmann, K Oechsle, D Quietzsch, A Wein, R D Hofheinz, F Honecker, O Nehls, C-H Köhne, G Käfer, L Kanz and C Bokemeyer

    Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

    doi:10.1038/sj.bjc.6601412

  • R-D Hofheinz, J T Hartmann, A Willer, K Oechsle, G Hartung, U Gnad, S Saussele, S Kreil, C Bokemeyer, R Hehlmann and A Hochhaus

    Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

    advance online publication, 2004-07-06 00:00:00.000;

    doi:10.1038/sj.bjc.6602025